TipRanks
Advertisement
Advertisement

OVID Stock Latest News

Ovid Therapeutics price target raised to $5 from $4 at H.C. Wainwright
The FlyOvid Therapeutics price target raised to $5 from $4 at H.C. Wainwright
7d ago
OVID
Ovid Therapeutics price target raised to $8 from $7 at Roth Capital
PremiumThe Fly
Ovid Therapeutics price target raised to $8 from $7 at Roth Capital
15d ago
OVID
Ovid Therapeutics: Buy Rating on Advancing OV329 Seizure Pipeline and Strong Cash Runway Through 2029
PremiumRatings
Ovid Therapeutics: Buy Rating on Advancing OV329 Seizure Pipeline and Strong Cash Runway Through 2029
1M ago
OVID
Ovid Therapeutics reports Q2 EPS (8c), consensus (10c)
PremiumThe Fly
Ovid Therapeutics reports Q2 EPS (8c), consensus (10c)
1M ago
OVID
Reiterated Buy Rating on Ovid Therapeutics as Solid Pipeline Execution and Two-Year Cash Runway Support Unchanged $5 Price Target
PremiumRatings
Reiterated Buy Rating on Ovid Therapeutics as Solid Pipeline Execution and Two-Year Cash Runway Support Unchanged $5 Price Target
1M ago
OVID
Ovid Therapeutics: Buy Rating Backed by De-Risked Balance Sheet and Differentiated Epilepsy Pipeline (OV329, OV4071)
PremiumRatingsOvid Therapeutics: Buy Rating Backed by De-Risked Balance Sheet and Differentiated Epilepsy Pipeline (OV329, OV4071)
1M ago
OVID
Ovid Therapeutics price target raised to $9 from $7 at Oppenheimer
Premium
The Fly
Ovid Therapeutics price target raised to $9 from $7 at Oppenheimer
2M ago
OVID
Ovid Therapeutics appoints Charles Carter as new CFO
Premium
Company Announcements
Ovid Therapeutics appoints Charles Carter as new CFO
2M ago
8K
OVID
Ovid Therapeutics CFO Jeffrey Rona to step down, Charles Carter to succeed
PremiumThe Fly
Ovid Therapeutics CFO Jeffrey Rona to step down, Charles Carter to succeed
2M ago
OVID
Ovid Therapeutics Shareholders Back Board and Governance Proposals
PremiumCompany Announcements
Ovid Therapeutics Shareholders Back Board and Governance Proposals
3M ago
8K
OVID
Ovid Therapeutics Expands Board, Appoints New Scientific Director
PremiumCompany Announcements
Ovid Therapeutics Expands Board, Appoints New Scientific Director
4M ago
8K
OVID
Ovid Therapeutics: Advancing Seizure Pipeline and Neuropsychiatric Programs Support Buy Rating and Unchanged $4 Price Target
PremiumRatings
Ovid Therapeutics: Advancing Seizure Pipeline and Neuropsychiatric Programs Support Buy Rating and Unchanged $4 Price Target
4M ago
OVID
Ovid Therapeutics price target raised to $7 from $5 at Roth Capital
PremiumThe FlyOvid Therapeutics price target raised to $7 from $5 at Roth Capital
4M ago
OVID
Ovid Therapeutics reports Q1 EPS (12c), consensus (11c)
Premium
The Fly
Ovid Therapeutics reports Q1 EPS (12c), consensus (11c)
4M ago
OVID
OVID Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
OVID Earnings this Week: How Will it Perform?
4M ago
OVID
Ovid Therapeutics files to sell 29.86M shares of common stock for holders
PremiumThe Fly
Ovid Therapeutics files to sell 29.86M shares of common stock for holders
5M ago
OVID
Ovid Therapeutics Boosts Capital Through Warrant Exercises
PremiumCompany Announcements
Ovid Therapeutics Boosts Capital Through Warrant Exercises
5M ago
8K
OVID
Ovid Therapeutics: Differentiated KCC2 ‘Master Switch’ Platform and Strong Cash Runway Underpin Buy Rating
PremiumRatings
Ovid Therapeutics: Differentiated KCC2 ‘Master Switch’ Platform and Strong Cash Runway Underpin Buy Rating
5M ago
OVID
Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
PremiumRatings
Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
5M ago
OVID
Ovid Therapeutics price target raised to $4 from $2 at H.C. Wainwright
PremiumThe FlyOvid Therapeutics price target raised to $4 from $2 at H.C. Wainwright
5M ago
OVID
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
5M ago
IVA
OVID
Ovid Therapeutics price target raised to $7 from $5 at Wedbush
Premium
The Fly
Ovid Therapeutics price target raised to $7 from $5 at Wedbush
6M ago
OVID

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >